52520-62-4

Basic information

• Product Name: (2S)-4-benzyl-2-<<(p-tolylsulfonyl)oxy>methyl>morpholine
• Synonyms: (2S)-4-benzyl-2-<<(p-tolylsulfonyl)oxy>methyl>morpholine
• CAS NO: 52520-62-4
• Molecular Weight: 361.462
• Mol File: 52520-62-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (2S)-4-benzyl-2-<<(p-tolylsulfonyl)oxy>methyl>morpholine(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-4-benzyl-2-<<(p-tolylsulfonyl)oxy>methyl>morpholine(52520-62-4)
• EPA Substance Registry System: (2S)-4-benzyl-2-<<(p-tolylsulfonyl)oxy>methyl>morpholine(52520-62-4)

Safety Data

• Hazardous Substances Data: 52520-62-4(Hazardous Substances Data)

Upstream product

• 104-63-2 N-Benzylethanolamine 
• 98-59-9 p-toluenesulfonyl chloride 
• 132073-82-6 (S)-4-Benzyl-2-(hydroxymethyl)morpholine 

Downstream Products

• 1174913-80-4 tert-butyl (2R)-2-(aminomethyl)morpholine-4-carboxylate 
• 148638-76-0 tert-butyl (2S)-2-({[(4-methylphenyl)sulfonyl]oxy}methyl)morpholine-4-carboxylate 
• 52730-46-8 (S)-2-(2-ethoxy-phenoxymethyl)-morpholine 
• 141196-43-2 (2S)-4-benzyl-2-(methoxymethyl)morpholine 

Relevant articles and documents

Novel Triazolopyrazine Derivatives and Use Thereof

The present invention relates to novel triazolopyrazine derivatives or a pharmaceutically acceptable salt, and a pharmaceutical composition for inhibiting c-Met tyrosine kinase activity and a pharmaceutical composition for preventing or treating hyperproliferative disorders, containing the same as active ingredients. The present invention effectively inhibits c-Met tyrosine kinase activity, thereby being able to be useful as a drug for various hyperproliferative disorders such as cancers, psoriasis, rheumatoid arthritis, diabetic retinitis, etc. related to excessive cell proliferation and growth by abnormal kinase activation.

Morpholine derivatives

The disclosure relates to new morpholine derivatives which possess antidepressant activity, to processes for the manufacture of said derivatives and to pharmaceutical compositions containing them. Typical of the morpholine derivatives disclosed is 2-(4H-2